Drug exports rise 4%

Exports of medical drugs increased by 4 percent to $2.3 billion in the first nine months of the year compared with the same period last year, the Israel Manufacturers' Association reported on Monday.

By SHARON WROBEL
November 27, 2007 08:15

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Exports of medical drugs increased by 4 percent to $2.3 billion in the first nine months of the year compared with the same period last year, the Israel Manufacturers' Association reported on Monday. According to the report, locally manufactured drugs are exported to 120 countries. In the January to September period, exports of local drugs to the US fell by 6% to $1.71b. as exports to the European Union rose by 43% to $393m. The Manufacturers' Association added that the decline in exports to the US was a result of the erosion of prices of generic drugs sold in the US and did not represent a decline in the volume of exports.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS